Source: International Congress 2016 – Best abstracts in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Claus Bachert (Ghent, Belgium), Claus Bachert, Peter Hellings, Joaquim Mullol, Daniel Hamilos, Robert Naclerio, Vijay N. Joish, Leda Mannent, Robert E. Evans, Annette Grabher, Adeline Abbe, Caroline Amand, Christine Taniou, Donghui Zhang, Chunpeng Fan, Gianluca Pirozzi, Neil Graham, Vera Mastey, Puneet Mahajan, Heribert Staudinger, Laurent Eckert, Asif Khan. Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial. Eur Respir J 2016; 48: Suppl. 60, 251

Member's Comments

No comment yet.

Related content which might interest you: Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Improvement in rhinosinusitis health related quality of life in patients with severe eosinophilic asthma Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Quality of life, clinical symptoms and nasal obstruction in patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Monitoring asthma in childhood: symptoms, exacerbations and quality of life Source: Eur Respir Rev 2015; 24: 187-193 Year: 2015 Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis and comorbid asthma status Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Predictors of psychiatric disorders in COPD patients Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Depressive symptomatology in COPD patients Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Sleep quality in patients with asthma and COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Predictors of respiratory health status in patients with severe asthma Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021